Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Dow
Argus Health
Harvard Business School
Johnson and Johnson
Queensland Health
Fish and Richardson
Deloitte
Farmers Insurance

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012813

« Back to Dashboard

NDA 012813 describes BLEPHAMIDE, which is a drug marketed by Allergan and is included in two NDAs. It is available from two suppliers. Additional details are available on the BLEPHAMIDE profile page.

The generic ingredient in BLEPHAMIDE is prednisolone acetate; sulfacetamide sodium. There are eighty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the prednisolone acetate; sulfacetamide sodium profile page.
Summary for 012813
Tradename:BLEPHAMIDE
Applicant:Allergan
Ingredient:prednisolone acetate; sulfacetamide sodium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 012813
Suppliers and Packaging for NDA: 012813
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BLEPHAMIDE prednisolone acetate; sulfacetamide sodium SUSPENSION;OPHTHALMIC 012813 NDA Allergan, Inc. 11980-022 N 11980-022-05
BLEPHAMIDE prednisolone acetate; sulfacetamide sodium SUSPENSION;OPHTHALMIC 012813 NDA Allergan, Inc. 11980-022 N 11980-022-10

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;OPHTHALMICStrength0.2%;10%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Moodys
Deloitte
Federal Trade Commission
Accenture
Cipla
QuintilesIMS
Citi
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.